002262.SZ · 恩华药业
China A-shares · RS rating 74 · As of 2026-10-14
| Price | 21.40 CNY |
|---|---|
| 1-day change | -0.9% |
| RS rating (overall / 1M / 3M / 12M) | 74 / 63 / 74 / 38 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 24 / 20 / 25 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -0.1% |
| Distance from 52-week high | +26.0% |
| Market cap (USD) | $3.3B |